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The adhesion GPCR Gpr56 regulates
oligodendrocyte development via interactions
with Ga12/13 and RhoA
Sarah D. Ackerman1, Cynthia Garcia2, Xianhua Piao3, David H. Gutmann2 & Kelly R. Monk1,4
In the vertebrate central nervous system, myelinating oligodendrocytes are postmitotic and
derive from proliferative oligodendrocyte precursor cells (OPCs). The molecular mechanisms
that govern oligodendrocyte development are incompletely understood, but recent studies
implicate the adhesion class of G protein-coupled receptors (aGPCRs) as important
regulators of myelination. Here, we use zebraﬁsh and mouse models to dissect the function of
the aGPCR Gpr56 in oligodendrocyte development. We show that gpr56 is expressed during
early stages of oligodendrocyte development. In addition, we observe a signiﬁcant reduction
of mature oligodendrocyte number and myelinated axons in gpr56 zebraﬁsh mutants. This
reduction results from decreased OPC proliferation, rather than increased cell death or
altered neural precursor differentiation potential. Finally, we show that these functions are
mediated by Ga12/13 proteins and Rho activation. Together, our data establish Gpr56 as a
regulator of oligodendrocyte development.
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M
yelin is a multilamellar, lipid-rich membrane that
insulates axons in the vertebrate nervous system to
facilitate the rapid conduction of action potentials1. In
addition, myelinating glia promote neuronal health by providing
vital trophic support to the axons they ensheath2,3. Myelin is
generated by specialized glial cells—Schwann cells (SCs) in the
peripheral nervous system (PNS) and oligodendrocytes in
the central nervous system (CNS)1. Oligodendrocytes form the
myelin sheath by extending and iteratively wrapping their plasma
membranes around axons, while glial cell cytoplasm is extruded
to ultimately form compact myelin4. Impaired myelination causes
debilitating symptoms in many severe neurological disorders such
as multiple sclerosis, and loss of mature oligodendrocytes and
myelin can lead to neuronal death and eventual paralysis.
Therefore, continued research to uncover new pathways that
promote oligodendrocyte development and remyelination is
essential5.
Although myelin is required for human life, the molecular
mechanisms that underlie glial cell development and myelination
are incompletely understood. Previous studies indicate that
extracellular matrix proteins and their receptors, in addition to
intracellular signal-transduction cascades, are essential for proper
development of myelinating glial cells6,7. For this reason,
adhesion G protein-coupled receptors (aGPCRs) represent good
candidate regulators of glial cell development and myelination
because they are purported to regulate both cell–cell and cell–
matrix interactions as well as signal-transduction by
heterotrimeric G proteins8, and recent studies implicate
aGPCRs as important regulators of myelination9–13. Indeed, the
aGPCR Gpr126 is essential for SC, but not oligodendrocyte,
myelination10–13.
aGPCRs are the second largest class of GPCRs, but remain
relatively understudied due to their structural complexity. In
addition to the canonical seven-transmembrane (7TM) domain
common to all GPCRs that usually facilitates intracellular
signalling, aGPCRs are characterized by the presence of a very
large N-terminal domain rich in functional motifs associated with
cell–cell and cell–matrix adhesion, which is separated from the
7TM by a GPCR proteolytic site (GPS)14. The GPS motif
is encompassed by a larger GPCR autoproteolysis-inducing
(GAIN) domain15. Together, these domains are required for
autoproteolytic cleavage of the N terminus from the C terminus, a
process that may be required for proper intracellular aGPCR
trafﬁcking and signalling15,16. The dual roles of aGPCRs in
promoting cell–cell/cell–matrix interactions and facilitating
intracellular signalling, in addition to the importance of
Gpr126 for SC myelination10–13, led us to hypothesize that
additional aGPCRs regulate glial cell development and
myelination in the CNS.
Previously published data sets indicate that Gpr56, an aGPCR
related to Gpr126, is highly expressed during mouse CNS
development in oligodendrocyte precursor cells (OPCs)17,18.
In addition, mutations in GPR56 in humans cause bilateral
frontoparietal polymicrogyria (BFPP)19, a cortical brain
malformation associated with a variety of devastating neuro-
logical impairments such as epilepsy and mental retardation.
Interestingly, brains of BFPP patients also exhibit reduced white
matter volume by MRI20–22, indicative of myelin defects. Taken
together, these data suggest that Gpr56 may function in
oligodendrocyte development. To test this hypothesis, we utilize
zebraﬁsh and mouse model systems to explore the necessity of
Gpr56 in the CNS. We show that impaired Gpr56 function results
in reduced numbers of myelinating oligodendrocytes and
hypomyelination due to decreased OPC proliferation rather
than failed speciﬁcation of the oligodendrocyte lineage. In
addition, transient overexpression of gpr56 in wild-type (WT)
zebraﬁsh increases numbers of pro-oligodendrocytes but inhibits
terminal differentiation of mature oligodendrocytes. Finally, we
show that these functions are mediated by interactions with Ga12/
13 G-proteins and RhoA signalling. Together, our studies
implicate Gpr56 as an essential regulator of oligodendrocyte
development and myelination.
Results
gpr56 is expressed during oligodendrocyte development. Mye-
lin is an evolutionary innovation of the jawed vertebrate lineage23,
and zebraﬁsh represent one of the simplest genetically tractable
organisms in which to study myelinating glial cell development.
We therefore took advantage of the zebraﬁsh model system to
interrogate the necessity of Gpr56 function in oligodendrocyte
development and myelination. First, we analysed the
spatiotemporal expression of gpr56 by RT–PCR in developing
zebraﬁsh. We detected gpr56 expression during embryogenesis
and in early larval stages (2 through 5 days post-fertilization
(dpf)) when OPCs are ﬁrst speciﬁed and differentiated24 (Fig. 1a).
In addition, whole-mount in situ hybridization (WISH) revealed
low levels of gpr56 expression throughout the CNS at 1 dpf,
before OPC speciﬁcation24 (Fig. 1b). These ﬁndings are consistent
with previously published data in mammals showing that Gpr56
is also expressed in astrocytes, and to a lesser extent, in neurons18.
At 2 dpf, when OPCs have been speciﬁed and are actively
migrating and dividing24, there was a marked increase in gpr56
expression in the CNS (Fig. 1c). Cross-sections of 2 dpf WISH
embryos revealed that gpr56 is expressed along the spinal cord
midline and in a single distinct band running dorsal to ventral on
either side of the midline, consistent with expression in neural
precursors (Fig. 1d). In contrast, gpr56 expression was not
detected by WISH in the CNS at larval stages 43 dpf
(Supplementary Fig. 1a,b), during which time oligodendrocytes
undergo terminal differentiation24,25. We also never detected
signal in sense control WISH experiments (Supplementary
Fig. 1c). These ﬁndings demonstrate that gpr56 expression
during CNS development is conserved from zebraﬁsh to
mammals and suggest that levels are highest at earlier stages.
Targeted disruption of gpr56 in zebraﬁsh. Given the expression
pattern of gpr56 in the developing CNS, we sought to test the
hypothesis that Gpr56 regulates oligodendrocyte development. To
this end, we generated Transcription Activator-Like Effector
Nucleases (TALENs)26 designed to cleave zebraﬁsh gpr56
genomic sequences between exons 8 and 9 (Fig. 1e), which
encode the GPS motif. We recovered two mutant alleles of gpr56:
stl13 representing a 6 bp deletion that is predicted to remove a
completely conserved tryptophan residue, and stl14 representing
a 26 bp deletion (Fig. 1f,g). The GPS is a cysteine-rich domain
containing four cysteine residues and two tryptophan residues
required for autoproteolytic cleavage27. Previous reports show
that inhibiting autoproteolytic cleavage of GPR56 prevents
receptor trafﬁcking and therefore impairs signalling20. In
addition, two missense mutations that disrupt the highly
conserved cysteine and tryptophan residues in humans cause
BFPP27. Together, these ﬁndings suggest that gpr56stl13/stl13
mutants may generate a non-functional Gpr56 due to failed
trafﬁcking of the receptor to the plasma membrane. Therefore, we
chose to primarily characterize and utilize stl13 as a tool for
understanding gpr56 function.
Gpr56 is required for proper oligodendrocyte development. To
determine whether Gpr56 is required for normal oligoden-
drogliogenesis, we performed marker analyses to observe
oligodendrocyte development in gpr56stl13/stl13 mutants. In the
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CNS, OPCs differentiate from neural progenitors that reside
within subventricular zones of the embryonic brain and spinal
cord through coordinated expression of the transcription factors
Olig2 and Sox10 (ref. 28). Some OPCs remain as non-myelinating
OPC progenitors throughout life, while others are further
speciﬁed by expression of the transcription factor Nkx2.2,
which allows OPCs to enter the terminal differentiation path-
way. Expression of Nkx2.2 is characteristic of axon-associated
pro-oligodendrocytes (pro-OLs)25, and mature myelinating oligo-
dendrocytes express Myelin basic protein (Mbp), which encodes a
structural component of the myelin sheath28. Using transgenic
sox10( 7.2):memgfp zebraﬁsh (a kind gift from M. Voigt,
manuscript in preparation), we did not detect any difference in
the number of sox10þ OPCs in gpr56stl13/13 larvae (N¼ 19)
compared with controls (N¼ 20) at 28 hours post-fertilization
(hpf), the earliest time point at which sox10 expression was
detected (Fig. 2a–c, Po0.09, Student’s t-test). These data suggest
that speciﬁcation of the oligodendrocyte lineage is not impaired
in gpr56stl13/stl13 mutants. Consistent with this observation,
general dorsal-ventral patterning (visualized by Sonic hedgehog
pathway markers) was also unaffected in gpr56stl13/13 mutants
(Supplementary Fig. 2). Furthermore, we did not observe overt
defects in the development of neurons, radial glia, or in microglia
number at any stage examined in gpr56stl13/13 mutants compared
with controls (Supplementary Fig. 3). However, by 2.5 dpf, we
detected a signiﬁcant decrease (Po5.223x10 6, Student’s t-test)
in nkx2.2aþ pro-OL number in gpr56stl13/13 mutants (N¼ 19) by
WISH relative to controls (gpr56þ /þ and gpr56stl13/þ : N¼ 22),
and we observed a subsequent reduction in CNS mbp expression
in gpr56 mutants (gpr56stl13/stl13: N¼ 20/27, gpr56stl14/stl14:
N¼ 14/19) by 4 dpf (Fig. 2d–i, WT control: N¼ 13/13).
Although gpr56 is maternally expressed (Fig. 1a), we did not
observe enhanced defects in oligodendrocyte development in
gpr56stl13/stl13 maternal-zygotic mutants (no WT maternal
contribution) compared with gpr56stl13/stl13 zygotic mutants
(Fig. 2j, N¼ 5/5). Importantly, injection of synthetic mRNA
encoding WT zebraﬁsh (50 pg) or mouse (200 pg) Gpr56 was
sufﬁcient to rescue the CNS mbp deﬁcits in gpr56stl13/stl13
mutants, conﬁrming the speciﬁcity of the TALEN-induced
mutations (Supplementary Fig. 4). Together, these results
demonstrate that Gpr56 is required for the proper development
of mature, myelinating oligodendrocytes.
Mutations in gpr56 cause CNS hypomyelination. To further
delineate how impaired Gpr56 function affects oligodendrocyte
myelination, we performed transmission electron microscopy
(TEM) to measure the extent and quality of myelin present
in the ventral spinal cord of gpr56 mutants (gpr56stl13/stl13:
N¼ 5, gpr56stl14/stl14: N¼ 4, WT: N¼ 6) during development
(Fig. 3a–k). We found a signiﬁcant reduction (gpr56stl13/stl13,
Po0.019; gpr56stl14/stl14, Po0.039, Student’s t-test) in the percent
of myelinated axons in mutant larvae compared with WT con-
trols at 5 dpf (Fig. 3l), but total axon number was unchanged
(gpr56stl13/stl13, Po0.5; gpr56stl14/stl14, Po0.78, Student’s t-test
Fig. 3m). We also did not observe a change in the number of
myelin wraps surrounding those axons that were myelinated in
gpr56stl13/stl13 mutants compared with controls (Fig. 3n,o; non-
Mauthner: gpr56stl13/stl13: Po0.29, gpr56stl14/stl14: Po0.6;
Mauthner: gpr56stl13/stl13: Po0.25, gpr56stl14/stl14: Po0.76, Stu-
dent’s t-test). In contrast to the hypomyelination phenotype
shown in the ventral spinal cord of gpr56 mutants at 5 dpf
(Fig. 3f–k), we did not observe any effect on oligodendrocyte
myelination in the dorsal spinal cord at this developmental stage
(Supplementary Fig. 5). By 21 dpf, however, we observed a sta-
tistically signiﬁcant decrease in the percent of myelinated axons
in the ventral (Po0.007, Student’s t-test) and dorsal (Po0.002)
spinal cord of gpr56stl13/stl13 (N¼ 4) mutants relative to WT
siblings (N¼ 2), with no change in axon number (Supplementary
Fig. 6, dorsal spinal cord: Po0.89, ventral spinal cord: Po0.96,
Student’s t-test). We suspect that we were unable to detect a
difference in the dorsal spinal cord at larval stages because very
few axons are myelinated in this region at 5 dpf. Interestingly, we
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Figure 1 | gpr56 expression and mutant generation in zebraﬁsh.
(a) Representative image of gpr56 expression assessed by RT–PCR from
fertilization through larval development (three technical replicates). From
left to right: Mat (maternal expression), 8 h (8 h post-fertilization), 1 d (days
post-fertilization) to 5 d, RT (-) control and H20 control. (b,c) Whole-mount
in situ hybridization (WISH) of zebraﬁsh larvae at (b) 1 and (c) 2 dpf shows
robust gpr56 expression within the central nervous system (black arrows in
b) during larval development (lateral views shown, anterior to the left,
dorsal is up, two technical replicates performed). (d) Cross-section through
the spinal cord (white dashed line in c depicts approximate location) of
gpr56 WISH embryo at 2 dpf shows gpr56 expression in the spinal cord
midline (white arrow) and in bands consistent with neural precursors (black
arrows). (e) Diagram of the zebraﬁsh gpr56 gene (top) and protein
(bottom) structures. TALENs used to generate gpr56 zebraﬁsh mutants
targeted between the 8th and 9th exons (text in red). Gpr56 contains a
signal sequence (ss), GPCR Autoproteolysis-Inducing Domain (GAIN),
GPCR Proteolytic Site (GPS) and the canonical 7-Transmembrane Domain
(7TM). (f) Recovered mutant alleles of gpr56—stl13 representing a 6-bp
deletion and stl14 representing a 26 bp deletion. (g) Amino-acid sequence
alignment of the GPS motif from representative species showing perfect
conservation of the Trp residue that is deleted in the gpr56stl13/stl13 allele
(highlighted yellow). Mutation of the second, highly conserved Trp residue
within the GPS causes BFPP (black arrowhead).
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reticulum in gpr56stl13/stl13mutants at 21 dpf, which was rarely
seen in controls, supporting the hypothesis that the protein
encoded by gpr56stl13/stl13 does not trafﬁc properly from the
endoplasmic reticulum to the plasma membrane (Supplementary
Fig. 6). To determine if myelination is simply delayed in
gpr56stl13/stl13 mutants, we analysed myelin ultrastructure in the
spinal cord of gpr56stl13/stl13 animals at 6 months of age
(Supplementary Fig. 7). At 6 months, we likewise found a sta-
tistically signiﬁcant decrease in the percent of myelinated axons
in gpr56stl13/stl13 mutants (N¼ 4) compared with WT controls
(N¼ 3) in both the ventral (Supplementary Fig. 7g, axon diameter
of 0.2–0.5mm (Po0.021), 0.5–1mm (Po0.005) and 1–2 mm
(Po0.029), Student’s t-test) and dorsal spinal cord
(Supplementary Fig. 7n, axon diameter of 0.2–0.5 mm (Po0.003)
and 0.5–1mm (Po0.008), Student’s t-test), without any change in
myelin thickness for axons that were myelinated (Supplementary
Fig. 7h,o, linear regression analysis). Axon number was also
unchanged in mutants compared with controls (Supplementary
Fig. 7f,m, dorsal spinal cord: Po0.11, ventral spinal cord:
Po0.34, Student’s t-test). Collectively, our analysis demonstrates
that altered Gpr56 function causes developmental CNS hypo-
myelination that persists in the adult spinal cord.
Gpr56 is not required for neural stem cell differentiation. One
possible explanation for the observed decrease in myelinating
oligodendrocyte numbers in gpr56stl13/stl13 mutants could be
reduced differentiation of the oligodendrocyte lineage from
neural stem cells. The fact that we did not detect defects in early
OPC speciﬁcation (Fig. 2a–c) in gpr56stl13/stl13 zebraﬁsh mutants
argued against this, but, to deﬁnitively test this model, we har-
vested neurospheres from the subventricular zone of Gpr56 /
knockout mice29 at postnatal day 3 and assessed their ability to
differentiate into Tuj1þ neurons, GFAPþ astrocytes and O4þ
oligodendrocytes. Importantly, we found robust levels of the
Gpr56 protein in neurospheres harvested from WT and Gpr56
þ / animals, which was absent from mutant neurospheres
(Supplementary Fig. 8). We observed no differences in the ability
of Gpr56 / neural stem cells to differentiate into any cell-type
tested (Fig. 4), consistent with our analysis of gpr56stl13/stl13
zebraﬁsh mutants (Fig. 2a–c; Supplementary Fig. 3). Of note,
neurospheres harvested from the spinal cord of Gpr56 /
animals showed a slightly increased potential to differentiate into
neurons (Supplementary Fig. 9), highlighting the variation that
exists between neural progenitor populations from different
tissues30. Importantly, neurospheres harvested from both tissues
showed no difference in their ability to differentiate into
oligodendrocytes compared with controls, supporting the
hypothesis that Gpr56 is not required for speciﬁcation and
differentiation of the oligodendrocyte lineage.
Gpr56 regulates OPC proliferation. Because OPC speciﬁcation
is unaffected in gpr56stl13/stl13 zebraﬁsh mutants, and loss of
Gpr56 does not affect the ability of neural precursors to differ-
entiate into oligodendrocytes, reduced pro-OL numbers in
gpr56stl13/stl13 mutants could result from increased death and/or
decreased proliferation of OPCs. To distinguish between these
possibilities, we performed time-lapse imaging of gpr56stl13/stl13
mutants and controls using transgenic sox10( 7.2):mRFP24
zebraﬁsh to visualize OPC behaviour and development in vivo
(Supplementary Movies 1 and 2). Embryos were imaged from 30
to 46 hpf, allowing us to monitor the transition of many OPCs
into pro-OLs. At 30 hpf, we found a statistically signiﬁcant
increase in the number of axons associated with pro-OLs in
gpr56stl13/stl13 mutants (N¼ 7) compared with controls (N¼ 7,
Po0.04, Student’s t-test). Over time, however, the number of
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Figure 2 | Oligodendrocyte development is impaired in gpr56 zebraﬁsh mutants. (a,b) Representative ﬂuorescent images of (a) control (gpr56stl13/þ )
and (b) gpr56stl13/13 larvae at 28 hpf expressing Tg(sox10( 7.2):memGFP) to mark OPCs. (c) Quantiﬁcation of OPC number (sox10þ ; white arrows) in
control (N¼ 20) and gpr56stl13/stl13 (N¼ 19) larvae. (d–f) Representative WISH images of the spinal cord of (e) gpr56stl13/stl13 (N¼ 19) and (d) control
embryos (gpr56þ /þ and gpr56stl13/þ , N¼ 22) showing nkx2.2a expression to mark pro-OLs. (f) Quantiﬁcation of pro-OL number (nkx2.2aþ )
(Po5.223 10 6). (g–j) mbp expression (CNS marked by white arrow, hindbrain) in (h) gpr56stl13/13 (N¼ 20/27), (i) gpr56stl14/stl14 (N¼ 14/19) and
(j) MZgpr56stl/13/stl13(5/5) larvae compared with (g) WT controls at 4 dpf (N¼ 13/13). (a–f) All images and quantiﬁcation thereof were taken from
segments 5 to 6 for consistency. For (a,b,d,e) lateral views are shown, anterior to the left, dorsal is up; for (g–j) dorsal views are shown, anterior to
the left. (a,b) Scale bar, 50mm. (d,e) Scale bar, 100 mm. (g–j) Scale bar, 200 mm. Student’s t-test used to test for statistical signiﬁcance and error bars
shown as±s.d. A minimum of two technical replicates were performed for each marker. NS, not signiﬁcant.
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rate than in gpr56stl13/stl13 mutants. This increase resulted in a
statistically signiﬁcant reduction in pro-OL associated axons in
gpr56stl13/stl13 mutants compared with controls by 46 hpf
(Fig. 5a–c, Po0.004, Student’s t-test), consistent with our
marker analysis (Fig. 2d–f). These ﬁndings suggest that in
gpr56stl13/stl13 mutants, OPCs are born and prematurely form
associations with axons, but that they do not proliferate
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to be myelinated. In accordance with this hypothesis, we also
observed additional myelinated axons in the ventral spinal cord of
gpr56stl13/stl13 mutants (N¼ 3) compared with controls (WT:
N¼ 3, gpr56stl13/þ  : N¼ 3) by TEM at 3 dpf (Fig. 5d–g,
Po0.048, Student’s t-test), indicative of precocious myelination.
In addition, we observed a statistically signiﬁcant reduction in the
number of proliferating OPCs (sox10þ ; pH3þ ) in gpr56stl13/stl13
mutants compared with controls at 32 hpf, when most OPCs have
not yet entered the differentiation programme24,25 (Fig. 5h–j,
Po0.0004, Student’s t-test). Importantly, we did not observe any
signs of cell death via time-lapse imaging, and there was no
increase in the number of cell corpses assessed by acridine orange
staining at 32 hpf, 2 dpf or 3 dpf in gpr56stl13/stl13 mutants
compared with controls (Fig. 5k–m). Thus, changes in pro-OL
number can only be attributed to changes in OPC proliferation
and not cell death. Together, these data support a model in which
Gpr56 promotes OPC proliferation at the expense of
differentiation such that, when Gpr56 function is impaired,
insufﬁcient OPC proliferation results in fewer pro-OLs and
mature oligodendrocytes, which leads to hypomyelination.
gpr56 OE increases OPC number but inhibits myelination.
Impaired Gpr56 function results in reduced numbers of
myelinating oligodendrocytes and myelin due to decreased OPC
proliferation (Figs 2, 3 and 5, Supplementary Figs 6 and 7).
Transient overexpression (OE) of WT Gpr56 synthetic mRNA
rescues CNS mbp expression (Supplementary Fig. 4) by
suppressing the OPC proliferation defect observed in
gpr56stl13/stl13mutants (Supplementary Fig. 10). Interestingly, we
also observed enhanced mbp expression in a large fraction of
gpr56-injected embryos (Supplementary Fig. 4d,e). We therefore
hypothesized that transient OE of gpr56 in WT embryos would
cause hypermyelination by increasing oligodendrocyte number.
Analysis of nkx2.2a expression revealed a statistically signiﬁcant
increase in the number of nkx2.2aþ pro-OLs in the anterior
(Po8.7x10 7, Student’s t-test) and posterior (Po0.01, Student’s
t-test) spinal cord (Fig. 6a–f) of embryos injected with 50 pg of
WT gpr56 synthetic mRNA (anterior: N¼ 25, posterior: N¼ 29)
relative to control-injected embryos (anterior: N¼ 26, posterior:
N¼ 31). In addition, we noted an increase in CNS mbp expres-
sion in gpr56-OE embryos relative to phenol-red-injected controls
by WISH (Fig. 6g–j, N¼ 19/34) at 2.5 dpf. Consistent with these
ﬁndings, we observed an increase in the numbers of oligoden-
drocyte lineage nuclei in the spinal cord of gpr56-OE embryos
relative to phenol-red-injected controls by TEM at 2.5 and 5 dpf
(Fig. 6l–q; Po0.037 at 2.5 dpf (OE: N¼ 4, control-injected:
N¼ 4); Po0.15 at 5 dpf (OE: N¼ 5, control-injected: N¼ 4),
Student’s t-test). We distinguished oligodendrocyte and OPC
nuclei from neuronal nuclei by their distinctive heterochromatin
conformations. OPC and oligodendrocyte heterochromatin is
heavily condensed and localized along the perimeter of the
nucleus for OPCs or in patches throughout for post-mitotic,
terminally differentiated oligodendrocytes. In contrast, neuronal
heterochromatin is organized uniformly throughout the nucleus,
often with a single dense nucleolus31–33. At 2.5 dpf, generally only
the large Mauthner axons are myelinated in WT zebraﬁsh34, but,
in some OE embryos, additional myelinated axons were observed
compared with controls at this time point by TEM (N¼ 2/4 in the
ventral spinal cord and N¼ 1/4 in the dorsal spinal cord,
Supplementary Fig. 11), although the difference was not
signiﬁcant. Taken alone, these data suggest that OE of gpr56
may induce hypermyelination; however, we observed
hypomyelination in gpr56 OE embryos relative to controls at 5
dpf by TEM (Fig. 6r–x). These ﬁndings indicate that OE of gpr56
increases mbp expression by increasing pro-OL number but that
this mbp expression is not equivalent to true myelination, and OE
of gpr56 inhibits terminal differentiation and myelination.
Collectively, these data support the hypothesis that Gpr56 is
both a positive regulator of OPC proliferation and a negative
regulator of oligodendrocyte differentiation.
Ga12/13 and RhoA manipulations alter gpr56 mutant pheno-
types. Previous in vitro studies show that Gpr56 couples to Ga12/
13 and activates RhoA to control migration of mammalian neural
precursor cells35,36. We likewise found that RhoA activity levels
are high in control neurospheres when Gpr56 is abundant
(Supplementary Fig. 12). In OPCs, RhoA is highly expressed, but
is later downregulated to facilitate terminal differentiation of
oligodendrocytes in mammals37, which is consistent with the
spatiotemporal expression proﬁle we observe for gpr56 in
zebraﬁsh (Fig. 1a–d). Taken together, these data suggest that
Gpr56 may couple to Ga12/13 and activate RhoA during
oligodendrocyte development. To test these hypotheses, we ﬁrst
used established antisense morpholino oligonucleotides that
transiently impair Ga12/13 function in gpr56stl13/stl13 mutants
through translational inhibition of three previously identiﬁed
Ga12/13 transcripts (‘3MO’; gna12, gna13a and gna13b)38. We
then analysed mbp expression by WISH to assess oligodendrocyte
development, and embryos were scored from 0 to 3 based on the
strength of their expression: 0¼ nearly absent, 1¼ strongly
reduced, 2¼ reduced, 3¼wild type (Fig. 7a–d). We treated
embryos with low doses of 3MO (1 ng each) such that WT, 3MO-
injected embryos showed no phenotype (Fig. 7e,f). In contrast,
sub-threshold doses of 3MO caused signiﬁcant hypomyelination
in gpr56stl13/þ heterozygotes and severe hypomyelination in
homozygous mutants, resulting in a marked shift in the
distribution of their phenotypic classes and a signiﬁcant
reduction in their CNS mbp score (Fig. 7e,f, control WT
(N¼ 23) versus control heterozygote (N¼ 56): Po0.077;
control WT (N¼ 23) versus control mutant (N¼ 32):
Figure 3 | gpr56 mutant spinal cord axons are hypomyelinated. (a) Schematic representation of a 5 dpf zebraﬁsh. Larvae were cut between segments 5
and 6 (red dashed line) and prepared for TEM. Axis shows orientation of the embryo (D, dorsal; V, ventral; A, anterior; P, posterior). (b) Diagram of
a 5 dpf zebraﬁsh cross-section, dorsal is up (D), ventral is down (V). In this image, the spinal cord is in orange and includes neuronal cell bodies (blue) and
myelinated axons (green). Ventral region used for quantiﬁcation is boxed in green, dorsal region used for quantiﬁcation boxed in magenta. Muscle in purple.
(c–k) Representative TEM images from the ventral spinal cord of WT (c–e, N¼ 6), gpr56stl13/stl13 mutant larvae (f–h, N¼ 5), and gpr56stl14/stl14 mutant
larvae (i–k, N¼4) at 5 dpf. Higher magniﬁcations of c,f,i are shown in d–e,g–h,j–k, respectively. (c,d,f,g,i,j) Myelinated axons are shaded
green, unmyelinated large caliber axons (Z 500nm) are shaded orange. (e,h,k) Images from panels d,g,j without pseudocolour. (l) Quantiﬁcation of the
percent of myelinated axons in the ventral spinal cord of gpr56stl13/stl13 (Po0.019) and gpr56stl14/stl14 (Po0.039) compared with WT controls.
(m) Quantiﬁcation of the total number of axons in the ventral spinal cord of gpr56stl13/stl13 (Po0.5) and gpr56stl14/stl14 (Po0.78) compared with WT
controls. (n,o) We also did not observe a signiﬁcant difference in the number of myelin wraps per myelinated axon in mutants compared with control on the
large caliber Mauthner axon (m) or on smaller caliber myelinated axons. (c,f,i) Scale bar, 1mm. (d,e,g,h,j,k) Scale bar, 500nm. (l–o) Quantiﬁcation
performed on a stereotyped 14mm2 region (b) in the ventral spinal cord. Student’s t-test used to test for statistical signiﬁcance and error bars shown
as±s.d. NS, not signiﬁcant. Data represent two technical replicates.
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Po0.0003; 3MO-injected WT (N¼ 10) versus 3MO-injected
heterozygote (N¼ 36): Po1.33x10 5; 3MO-injected WT
(N¼ 10) versus 3MO-injected mutant (N¼ 15): Po2.59x10 6,
Student’s t-test). As inhibition of Ga12/13 function preferentially
affects oligodendrocyte development in gpr56stl13/þ
heterozygotes and mutants compared with WT controls, our
ﬁndings suggest a genetic interaction and thus support the
hypothesis that Gpr56 promotes oligodendrocyte development
via interactions with Ga12/13.
Rho is the main downstream effector of Ga12/13 (ref. 39), and
previous studies in vitro implicate RhoA signalling downstream
of Gpr56 (refs 35,36). We therefore hypothesized that Gpr56
couples to Ga12/13 and signals through RhoA to promote
oligodendrocyte development. Consistent with this model,
transient OE of 10 pg of a constitutively active form of rhoa
(rhoV14)38 suppressed gpr56stl13/stl13 mutant phenotypes,
including the OPC proliferation defect (Supplementary Fig. 10)
and CNS mbp score (Fig. 7i,j, control WT (N¼ 22) versus control
mutant (N¼ 27): Po0.0009; OE WT (N¼ 16) versus OE mutant
(N¼ 17): Po0.343, Student’s t-test). OE of rhoa also caused a
marked shift in the distribution of phenotypic classes in gpr56stl13/
stl13 mutants such that the majority (76%) of gpr56stl13/stl13 larvae
expressed WT levels of mbp (Fig. 7i, N¼ 13/17). Importantly, all
embryos analysed for these studies were morphologically normal,
and thus changes in mbp expression could not be attributed to
changes in overall heath in treated animals compared with
controls (Fig. 7g,h,k and l). Taken together, these experiments
demonstrate that Gpr56 interacts with Ga12/13 and signals
through RhoA to promote oligodendrocyte development and
subsequent myelination.
Discussion
The timing of the transition from OPC proliferation to terminal
differentiation is tightly regulated40–42. In the CNS, interactions
between receptors on the OPC cell surface and axon-bound or
axon-secreted molecules ensure that sufﬁcient numbers of OPCs
are generated to accommodate the numbers of axons that need to
be myelinated. Availability of the axon-derived mitogen PDGF-A,
which interacts with PDGFRa on the OPC plasma membrane, is
a major determinant of the extent of OPC proliferation.
Moreover, numerous mechanisms converge to ensure the
timing and execution of terminal differentiation, including
downregulation of Pdgfra by Nkx2.2 in OPCs, cell-cycle exit
and vast morphological changes37,42–45. Failed differentiation of
resident OPC pools in response to demyelination is a major
contributor to the degenerative nature of demyelinating diseases
such as multiple sclerosis46; thus, identiﬁcation of signalling
molecules that regulate OPC behaviour and differentiation could
provide new avenues for therapeutics.
In this study, using zebraﬁsh and mouse models, we identiﬁed
Gpr56 as a new regulator of OPC proliferation and oligoden-
drocyte myelination. Like PDGFRa, Gpr56 expression is
restricted to early stages of oligodendrocyte development and is
downregulated before terminal differentiation18,42, suggesting


















































































Figure 4 | Loss of Gpr56 does not affect neural precursor differentiation capacity. Quantiﬁcation of the percent of (a) GFAPþ astrocytes, (b) Nestinþ
neural progenitors, (c) Tuj1þ neurons and (d) O4þ oligodendrocytes (per ﬁeld of view) differentiated from neural precursors harvested fromWT (N¼ 3),
Gpr56þ / (N¼4), and Gpr56 / (N¼ 5) animals at postnatal day 3 (P3). Representative ﬂuorescent images from each genotype shown to the right
of each summary graph. Two-way ANOVA used to test for statistical signiﬁcance and error bars shown as±s.d. Data were acquired from two technical
replicates.
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or positively regulate OPC behaviour/proliferation. Gpr17,
another GPCR that is essential for oligodendrocyte
development, is also expressed in OPCs and is downregulated
in mature oligodendrocytes, and Gpr17 has been shown to
directly inhibit terminal differentiation. In the absence of Gpr17,
OPCs prematurely differentiate and form myelin, though
myelination eventually proceeds to WT levels in Gpr17 /
mice47. We found that gpr56stl13/stl13 mutant OPCs likewise
formed associations with axons and myelinated prematurely,
indicative of precocious differentiation due to relieved inhibition
on terminal differentiation. We found that OPCs are speciﬁed
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30 hpf 38 hpf 46 hpf
Figure 5 | gpr56 mutant OPCs form premature associations with axons and are less proliferative than controls. (a,b) Representative stills from in vivo
time-lapse imaging of the spinal cord (white bracket at 16 h) from segments 5 to 7 of (a) controls (gpr56stl13/þ , N¼6) and (b) gpr56stl13/stl13 mutants
(N¼ 7) expressing tg(sox10( 7.2):mRFP) to visualize OPC behaviour over time (three technical replicates performed). Embryos were imaged from 30 to
46 hpf to encompass the transition of OPCs (white arrowheads) into pro-OLs (light green arrowheads). White arrows denote sox10 expressing neural crest
cells, and orange arrows mark the posterior lateral line nerve, which is part of the peripheral nervous system and is marked by the presence of migrating
Schwann cell precursors. (c) Quantiﬁcation of the number of pro-OL associated axons over time in gpr56 mutants compared with controls at 30 hpf
(Po0.039), 38 hpf (Po0.28) and 46 hpf (P¼0.004). (d–f) Representative TEM images of the ventral spinal cord of a WT (d, N¼ 3) and gpr56stl13/stl13
(e,f, N¼4) embryo at 3 dpf (two technical replicates performed). (e) Additional non-Mauthner myelinated axons (shaded blue and numbered) were
observed in gpr56stl13/stl13 embryos (Po0.048) compared with controls. Mauthner axon shaded orange. (f) Image shows a higher magniﬁcation of panel e
(green box). (g) Raw counts of non-Mauthner myelinated axons in control and gpr56stl13/stl13 embryos at 3 dpf. (h,i) Representative ﬂuorescent images of
the spinal cord from segments 5 to 7 of (h) control (gpr56stl13/þ , N¼ 31) and (i) gpr56stl13/stl13 mutant (N¼ 34) embryos at 32 hpf (two technical replicates
performed). Embryos expressing tg(sox10 ( 7.2):mRFP) were ﬁxed and stained with pH3 to assay proliferation. (j) Quantiﬁcation of the number of
proliferating OPCs in gpr56stl13/stl13 mutants compared with controls (Po0.0004). (k–m) Quantiﬁcation of dying cells (acridine orange þ , one technical
replicate per time point) in gpr56stl13/stl13 mutants and controls (WT and gpr56stl13/þ ) at 32 hpf (control: N¼ 13, gpr56stl13/stl13: N¼ 20), 2 dpf (control:
N¼ 21, gpr56stl13/stl13: N¼ 12) and 3 dpf (control: N¼ 19, gpr56stl13/stl13: N¼ 20). (a,b,h,i) Scale bar, 50mm. (d,e) Scale bar, 1mm. (f) Scale bar, 500nm.
Student’s t-test used to test for statistical signiﬁcance and error bars shown as±s.d.
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resulting in reduced numbers of myelinating oligodendrocytes
and consequently hypomyelination. In addition, transient OE of
gpr56 in WT embryos caused increased numbers of pro-OLs and
increased mbp expression in gpr56 OE embryos at 2.5 dpf.
However, the apparent increase in mbp expression is likely the
result of greater numbers of pro-OLs, as myelination was
inhibited in the OE embryos at 5 dpf as assessed by TEM. We
also observed many immature oligodendrocyte cell bodies with
no axonal contacts in the centre of the spinal cord of the OE
embryos at this time point. These ﬁndings indicate that the
prolonged OE of gpr56 inhibits OPC differentiation and
myelination. Together, these ﬁndings support the hypothesis
that Gpr56 is both a positive regulator of OPC proliferation and
an inhibitor of oligodendrocyte terminal differentiation.
Though we observed striking defects in oligodendrocyte
development and myelination when Gpr56 function is
perturbed, we did not observe any defects in the development
of neurons, radial glia or in microglia number in gpr56stl13/stl13
mutants at any time point analysed. These data suggest that the
observed defects in oligodendrocyte development are a cell-
autonomous effect, although conditional mouse mutant studies
could be leveraged to deﬁnitively address the question of cellular
autonomy. Together, these data demonstrate that Gpr56 is a
positive regulator of OPC proliferation and a negative regulator of
OPC differentiation.
Previous in vitro studies place Ga12/13 and RhoA signalling
downstream of Gpr56 (refs 35,36). RhoA is the major downstream
effector of Ga12/13 and its expression is likewise restricted to early
stages of oligodendrocyte development37,39. Inactivation of RhoA
via Fyn is required for OPC morphological differentiation into
pro-OLs, and sustained OE of RhoA inhibits process extension
and differentiation of oligodendrocytes37. Reduction of Ga12/13
function in gpr56stl13/stl13 zebraﬁsh mutants and heterozygotes
causes enhanced loss of CNS mbp expression. In addition,
transient OE of constitutively active RhoA before terminal
differentiation suppressed gpr56stl13/stl13 defects. In sum, these
data support a model in which Gpr56 function in OPCs is
mediated via interactions with Ga12/13 and RhoA signalling.
RhoA has not been shown to directly promote OPC pro-
liferation, though our ﬁndings do not preclude this possibility.
We therefore propose a model in which Gpr56 interacts with
Ga12/13 and activates RhoA to prevent OPC differentiation,
which facilitates continued OPC proliferation promoted by
axon–glia interactions such as those mediated by PDGFRa and
PDGF-A42–44. When Gpr56 function is perturbed, RhoA
activation is therefore reduced, relieving RhoA inhibition of
terminal differentiation and causing premature OPC
differentiation that manifests in a reduced proliferation
phenotype (Fig. 8). In this model, the OPCs that prematurely
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Figure 6 | Overexpression of gpr56 causes increased OPC number and inhibits myelination. (a–d) WISH shows nkx2.2a expression in the spinal cord of
injected WT larvae at 2.5 dpf. Lateral views are shown, dorsal is up. (e,f) Quantiﬁcation of the number of nkx2.2aþ pro-OLs (black arrowheads) in WT
embryos injected with 50 pg of synthetic gpr56 mRNA (N¼ 30) in the anterior (b, segments 5–6, Po8.7 10 7) and posterior (d, segments 15–30,
Po0.01) spinal cord compared with injected controls (a,c, N¼ 31). (g–j) Representative images of a (h,j) gpr56-injected WT larva (N¼ 19/31) compared
with a (g,i) control-injected embryo (N¼ 33/35) showing mbp expression by WISH. (g,h) Lateral views shown, anterior on right. (i,j) Dorsal views shown,
anterior on right. Black arrows. (k) Cartoon of zebraﬁsh larva in cross-section modiﬁed from Fig. 3b. White box represents regions shown in l,m,o,p. Green
box represents region shown in r–u. (l,m,o,p) Representative images of spinal cord cross-sections from 2.5 dpf (l,m) and 5 dpf (o,p) WTembryos injected
with control (l,o) or 50 pg gpr56 synthetic mRNA (m,p). 2.5 dpf: scale bar, 500nm. 5 dpf: scale bar, 4mm. (n,q) Quantiﬁcation of the number of
oligodendrocyte lineage cell bodies (shaded purple) in gpr56-injected embryos (N¼4) compared with controls (N¼4) at 2.5 dpf (Po0.037) and 5 dpf
(Po0.15, N¼4 for controls and N¼ 5 for gpr56-injected embryos). Neuronal cell bodies shaded green. (r–u) Representative TEM images of the spinal cord
in cross-section from 5 dpf control (r,s) and gpr56-injected (t,u) embryos. Scale bar, 1 mm. Quantiﬁcation of total axon number (v), % myelinated axons
(shaded blue, w, Po0.05) and myelin thickness on the large caliber Mauthner axon (shaded orange, x, Po0.008) in gpr56 OE embryos at 5 dpf relative to
controls. SC, spinal cord. Student’s t-test used to test for statistical signiﬁcance and error bars shown as±s.d. Two technical replicates were performed for
each overexpression experiment.
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Accordingly, we detected an increase in axons associated with pro-
OLs at 30 hpf and increased myelination at 3 dpf, consistent with
precocious differentiation. Furthermore, we observed no myelin
abnormalities or reduced myelin thickness in those axons that are
myelinated in gpr56stl13/stl13 mutants. In sum, these data support
the model that Gpr56 positively regulates OPC proliferation via
RhoA activation and inhibition of terminal differentiation.
At present, multiple ligands of Gpr56 have been identiﬁed in
other cell types. In cancer studies, Gpr56 has been shown to
inhibit melanoma cell growth via interactions with tissue
transglutaminase (TG2)48. In the developing brain, collagen
type III, alpha-1 secreted by meningeal ﬁbroblasts interacts with
neuron-bound Gpr56 to facilitate proper neuronal migration36.
Impaired differentiation of OPC progenitors is a major cause of
failed remyelination in the CNS of patients suffering from
demyelinating diseases such as multiple sclerosis46. Therefore, a
better understanding of Gpr56 activation and signalling is crucial
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Figure 7 | Manipulation of Ga12/13 and RhoA signalling inﬂuences CNS mbp expression in gpr56 mutants. (a–d) Injection of morpholinos (3MO)
targeting Ga12/13 signalling (gna12-MO, gna13a-MO and gna13b-MO, 1 ng each), constitutively active rhoa synthetic mRNA (10 pg), or phenol-red control
yielded embryos with (d) WT, (c) reduced, (b) strongly reduced or (a) nearly absent CNS mbp expression at 65 hpf by WISH (dorsal view shown, anterior
is up, white arrows denote CNS mbp expression). We scored mbp expression as follows: 3¼WT, 2¼ reduced, 1¼ strongly reduced, 0¼ nearly absent.
(e) Phenotypic distribution by genotype and treatment (1 ng 3MO or control-injected). (f) Quantiﬁcation of CNS mbp score by genotype and treatment
(1 ng 3 MO or control-injected). (f) Respective P values: control WTversus control heterozygote: Po0.077; control WTversus control mutant: Po0.0004;
3MO-injected WTversus 3MO-injected heterozygote: Po1.33 1005; 3MO-injected WTversus 3MO-injected mutant: Po2.59 10 6). (i) Phenotypic
distribution by genotype and treatment (10 pg consitutively active RhoA (rhoV14) or control-injected) (j) Quantiﬁcation of CNS mbp score by genotype
and treatment (10 pg consitutively active RhoA (rhoV14) or control-injected). Respective P-values: control WT versus control mutant: Po0.0009;
OE WT versus OE mutant: Po0.343. (g,h,k,l) All analysed injected embryos were morphologically normal. Student’s t-test used to test for statistical
signiﬁcance and error bars are shown as±s.d. Two technical replicates were performed for the 3MO and the OE experiment. NS, not signiﬁcant.
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OPC differentiation and remyelination after injury and disease-
induced demyelination. Further studies are required to identify
the endogenous ligand(s) and small molecules that modulate
Gpr56 signalling in OPCs.
Methods
Zebraﬁsh stocks and rearing conditions. Zebraﬁsh (Danio rerio) were main-
tained in the Washington University Zebraﬁsh Consortium facility (http://
zebraﬁsh.wustl.edu/husbandry.htm). All experiments were performed in com-
pliance with Washington University’s institutional animal protocols. Embryos were
collected from pair-wise or harem matings and reared at 28.5 C in egg water
(5mM NaCl, 0.17mM KCl, 0.33mM CaCl2, 0.33mM MgSO4). Embryos were
staged in hours post-fertilization (hpf) or days post-fertilization (dpf) using
morpholical markers49. To prevent pigmentation in embryos 41 dpf, egg water
was supplemented with phenylthiourea to 0.003%. The following lines of zebraﬁsh
were used for these studies: both alleles of gpr56 (stl13, stl14) were generated in a
WT (AB*) background. For marker analysis, we used the following transgenic
lines: tg(gfap:GFP)50, tg(sox10( 7.2):mRFP)24, tg(olig2:dsred)51, tg(HuC:kaede)52
and tg(sox10( 7.2):memgfp) that were a generous gift from Mark Voigt (St. Louis
University).
Genotyping. To genotype individual larvae for phenotypic analyses, we used the
following primers to amplify a 182 bp fragment of gpr56 from genomic DNA:
50-CATGGGATACAAAACAAGGT-30 and 50-AGTGGCATTCTGTCTGTTCT-30 .
For stl14, PCR products were run out on a 3% agarose gel and the smaller fragment
(158 bp) is the mutant allele. For stl13, we performed restriction digest analysis
using Hpy166II, which cleaves WT into a 61 bp and a 121 bp fragment, but is
unable to cut mutant (176 bp).
TALEN generation and microinjection:. TALEN constructs were assembled by
the Hope Center for Neurological Disorders at Washington University using the
Golden Gate TALEN assembly protocol53. The repeat variable diresidue sequences
for the left and right TALENs were as follows: Left: NN NG NG NG HD NG
HD HD HD NG NI NN NI HD NI NI NG and Right: NI NI HD NG NN NG NI
NG HD NN HD NI NN HD HD NI NG HD NI NG. Synthetic TALEN mRNA
was then transcribed using the mMESSAGE mMACHINE SP6 ULTRA kit
(Ambion), and RNA from each arm was combined and injected into single-cell
stage WT embryos (AB) at 100 pg quantities. To recover germ-line transmitted
mutations, injected founders (F0s) were raised to adulthood, outcrossed to WT AB
partners, and genomic DNA was extracted from individual F1 embryos for
PCR ampliﬁcation and restriction digest analysis of the targeted region. Genomic
DNA from F1 embryos that showed disruption of the target site was then cloned
using the TOPO TA Cloning kit (Invitrogen) and sequenced using Sanger
sequencing.
Mice. All mouse (Mus musculus) experiments were performed in compliance with
Washington University’s institutional animal protocols. The Gpr56-knockout mice
were obtained from the Mutant Mouse Regional Resource Centers (MMRRC),
were maintained on a C57BL/6 background and genotyped as described pre-
viously29. P3 animals of presumed mixed gender were used for all neurosphere
experiments, although pups were not genotyped for gender.
PCR with reverse transcription. Standard PCR with reverse transcription
(RT–PCR) was performed on cDNAs derived from embryos at the two-cell stage
(Maternal), 8 hpf, 24 hpf, 48 hpf, 72 hpf and 5 dpf. Analysis was performed three
separate times with similar results. For all stages, cDNA was reverse-transcribed
from RNA extracted from pools of 30 embryos with the SuperScript First-Strand
Synthesis system for RT–PCR (Invitrogen) using Superscript II reverse tran-
scriptase (RT) and oligo(dT) primers, and genomic DNA was controlled for by
omitting RT from reactions using the same RNA. To amplify gpr56, we used
primers that amplify a 602-bp fragment from exons 3 to 7: 50-TCATCCAGAA
GAGCTGATTT-30 and 50-GAAATTTCAGCCAATGAGAG-30 . gapdh was
ampliﬁed as a control to produce a 117-bp product: 50-TGACCCATTCATT
GACCTTG-30 and 50-GCATGACCATCAATGACCAG-30 .
Cloning. Full-length gpr56 cDNA was ampliﬁed from cDNA derived from 5 dpf
embryos and cloned into pCS2þ using the following primer set: 50-GATCTACTC
GAGTTGGTAGAAAGTGGACTTCG-30 (XhoI site underlined) and 50-AGGATA
TCTAGATTCCCTCACAACTTCACACT-30 (XbaI site underlined). Both vector
and insert were digested with XhoI and XbaI and ligated together using standard
T4 ligase (NEB), and the ﬁnal vector (pCS2þ _ zf_gpr56) was sequenced for
veriﬁcation.
In situ hybridization. Whole-mount in situ hybridizations were performed using
standard protocols54. In brief, embryos were ﬁxed at the desired age with 4%
paraformaldehyde for 2 h at room temperature or 4 C overnight, and then
dehydrated in 100% Methanol overnight. Following dehydration, embryos were
washed in 0.2% PBS-Tween (PBSTw), permeabilized in proteinase K (20mg ml 1
diluted 1:1,000 in 0.2% PBSTw), and incubated with the appropriate Digoxygenin-
labelled riboprobe overnight at 65 C in hybridization buffer (50% formamide).
Following probe treatment, embryos were washed to remove formamide,
blocked in 2% blocking medium supplemented with 10% normal sheep serum and
0.2% Triton, and incubated in the primary antibody (Anti-Dig, Fab fragments
(1:2,000), Roche) overnight in a block. Following primary antibody treatment,
embryos were washed in Maleic Acid Buffer with 0.2% Triton and developed by
alkaline phosphatase treatment. When complete, embryos were post-ﬁxed in 4%
paraformaldehyde and stored long-term in 70% glycerol. To synthesize gpr56
riboprobes, a 509-bp region spanning exons 11–13 was PCR ampliﬁed from a
partially sequenced cDNA clone (Clone ID 7070653, Open Biosystems) using





















Figure 8 | Gpr56 promotes OPC proliferation through inhibiting differentiation. Model of Gpr56 function in OPCs. In WT OPCs, Gpr56 couples to
Ga12/13 and activates RhoA, which prevents terminal differentiation and indirectly promotes OPC proliferation (dashed arrow) by maintaining the OPC in an
immature, proliferative state. OPC proliferation is directly regulated via interactions between neuron-secreted PDGF-A and OPC-bound PDGFRa. In
Gpr56 (stl13/stl13) mutant OPCs, impaired autoproteolytic cleavage reduces Gpr56 signalling capacity, leading to loss of RhoA activation. Reduced RhoA
signalling alleviates RhoA inhibition on terminal differentiation (green arrow), which indirectly causes a decrease in OPC proliferation (red dashed lines) as
OPCs differentiate at the expense of proliferation.
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The PCR product was cloned into pCR II using the pCR II- TOPO TA Cloning
kit (Invitrogen) and sequenced. This construct was linearized by NotI and
transcribed with SP6 for sense and linearized with BamHI and transcribed with T7
for antisense. All other riboprobes: mbp55, nkx2.2a56, apoeb57, shh58, ptc1 (ref. 59)
and ptc2 (ref. 60) were described previously. Embryos stained with nkx2.2a were
mounted in glycerol and nkx2.2a positive cells were counted manually in all focal
planes of the spinal cord from segments 5–7 or 15–30. apoeb positive microglia
were counted as previously described57. All quantiﬁcations were performed
blinded, and genotypes were obtained following quantiﬁcation.
Transmission electron microscopy. For zebraﬁsh larvae and 21 dpf juveniles,
TEM was performed using a PELCO BioWave Pro with SteadyTemp Digital Plus
water-recirculating system to ensure sufﬁcient inﬁltration of the embryos61.
Embryos were microwaved for all steps before EPON treatment. In brief, embryos
were ﬁxed in Karnovsky’s ﬁx (4% paraformaldehyde, 2% glutaraldehyde, 0.1M
sodium cacodylate) and left overnight at 4 C. After ﬁxation, embryos were post-
ﬁxed in 2% osmium tetroxide in 0.1M sodium cacodylate and 0.1M imidazole,
washed and treated with saturated uranyl acetate. Embryos were then dehydrated
using increasing concentrations of ethanol followed by 100% acetone, and then
inﬁltrated overnight in an acetone-EPON mixture. Embryos were then transferred
to 100% EPON and embedded in moulds for baking overnight at 65 C. We always
examined ﬁsh of a given stage at approximately the same body segment level to
control for variability along the anterior/posterior axis. For preparation of spinal
cords from 6–month- old adults, we anaesthetized animals in an ice-water bath and
then severed the hindbrain before dissecting a portion of the anterior spinal cord,
and ﬁxation of adult-tissue occurred as described previously10. In brief, adult
tissues were ﬁxed in Karnovsky’s ﬁx overnight, post-ﬁxed in 2% osmium tetroxide
in 0.1M sodium cacodylate, washed and dehydrated in increasing concentrations
of ethanol followed by 100% propylene oxide. The tissues were then submerged in a
2:1 mixture of propolyene oxide:EPON for 1 h, followed by a 1:1 mixture overnight.
The following day, the tissues were transferred to 100% EPON before embedding
and baking at 65 C. Thin sections (70 nm) were mounted on mesh (5 dpf and 6
month samples) or slot (21 dpf samples) grids and stained with 8% uranyl acetate
and Sato’s lead stain. Sections were then viewed on a Jeol (JEM-1400) electron
microscope and images were collected with an AMT V601 digital camera. All
images were processed and analysed using Image J software. At 3 and 5 dpf,
quantiﬁcations were performed on a stereotyped, 14 mm2 region of the dorsal or
ventral spinal cord containing B400 and 250 axons, respectively (see Fig. 3b). At
21 dpf, quantiﬁcations were performed on three, 20 mm2 sections of the ventral
spinal cord and two, 20mm2 sections of the dorsal spinal cord containing of a
minimum of 100 and 300 axons, respectively. Quantiﬁcations were performed on
stereotyped positions of the spinal cord (see Fig. 3b). At 6 months, quantiﬁcations
were performed on a stereotyped 17 mm2 region of the dorsal and ventral spinal
cord (Supplementary Fig. 7a). G-ratios were calculated using Adobe Photoshop and
Image J software for B50 axons per animal by taking the ratio of the axon
diameter to the diameter of the whole myelinated ﬁbre. At 3 dpf, N¼ 3 for WT and
gpr56stl13/þ , N¼ 4 for gpr56stl13/stl13. For quantiﬁcation of gpr56 mutants and
controls at 5 dpf, N¼ 6 for WT controls, N¼ 5 for gpr56stl13/stl13 mutants and
N¼ 4 for gpr56stl14/stl14 mutants. At 21 dpf, N¼ 2 for WT controls and N¼ 4 for
gpr56stl13/stl13 mutants. At 6 months, N¼ 3 for WT controls and N¼ 4 for
gpr56stl13/stl13 mutants.
For quantiﬁcation of gpr56-injected versus control-injected embryos at 2.5 and
5 dpf, we manually counted the number of wraps around Mauthner axons imaged
at  10,000. At 2.5 dpf, we quantiﬁed all neuronal/oligodendrocyte-lineage cell
bodies in the dorsal half of the spinal cord (located above half the height of the
whole spinal cord at  1,200). N¼ 4 for each treatment. At 5 dpf (N¼ 4 for
control-injected embryos, N¼ 5 for gpr56-injected embryos), we quantiﬁed
oligodendrocyte-lineage cell bodies within a stereotyped 30 mm2 region in the
centre of the spinal cord. Additional calculations were performed as described
above. All quantiﬁcations were performed blinded to genotype and treatment.
Culture and generation of neurospheres. For generation of neurospheres for
IHC analysis, spinal cords and subventricular zones (SVZ) were dissected from
postnatal (P) day 3 mice (Gpr56þ /þ : N¼ 3; Gpr56þ / : N¼ 4; Gpr56 / :
N¼ 5) to generate NPCs as previously reported62. In brief, spinal cords and SVZ
were removed from P3 mice and processed to obtain single-cell suspension of
neural progenitors (neurospheres). Dissected spinal cords and SVZ were digested
with trypsin digest buffer containing 0.2% BSA (Sigma), 0.5mgml 1 DNase I
(Sigma) and 10% trypsin-EDTA stock (BioWhittaker) in HBSS at 37 C for 15min
in a volume of 0.7ml l 1. Equal volumes of 10% FBS medium containing 10% FBS
(Life Technologies) and low glucose DMEM (Sigma) were added, and spinal cords
and SVZ were triturated with ﬁre-polished Pasteur pipettes. Pelleted cells were
washed with dissociation medium containing 15mM HEPES (Sigma), 0.5% glucose
in HBSS. Cells were ﬁnally resuspended in NSC medium containing a 5:3 mixture
of DMEM low glucose:Neurobasal medium (Life Technologies), 0.5mM 2-
mercaptoethanol, 2mM L-glutamine, 5 IU of penicillin and 5 mgml 1
streptomycin (BioWhittaker) supplemented with 1% N2 supplement (Life
Technologies), 2% B27 supplement (Life Technologies), 20 ngml 1 epidermal
growth factor (EGF) (Sigma) and 20 ngml 1 basic ﬁbroblast growth factor (FGF)
(R & D Systems). Cells were allowed to grow in culture for 6 days. For generation
of neurospheres for western blotting analysis, SVZ were dissected from P3 mice
(Gpr56þ /þ : N¼ 4; Gpr56þ / : N¼ 4; Gpr56 / : N¼ 3) and cultured as
described above.
Neurosphere immunocytochemistry. Immunocytochemistry was performed on
trypsinized NPCs grown in 50 mgml 1 poly-D-lysine-coated and 10mgml 1
ﬁbronectin-coated 24-well plates containing deﬁned medium [(5:3 mixture of
DMEM low glucose (Life Technologies): neurobasal medium (Life Technologies),
0.5mM 2-mercaptoethanol, 2mM L-glutamine, 5 IU of penicillin and 5 mgml 1
streptomycin (Life technologies) supplemented with 1% N2 supplement (Life
Technologies) and 2% B27 supplement (Life Technologies) without growth factors.
After 5 days in culture, cells were ﬁxed and stained with primary antibodies
(Nestin: ab6142 (Abcam), GFAP: G9269 (Sigma-Aldrich), Tuj1: MMS-435P
(Covance) and O4: MAB345 (Millipore)) at 4 C overnight. For ﬂuorescence
detection, Alexa Fluor-tagged secondary antibodies (Molecular Probes) were used
and cells were counterstained with DAPI. Images were acquired using Metamorph
software on a Nikon Eclipse TE300 microscope equipped with an optical camera
(Optronics). Investigators were blinded to mouse genotypes and percentages of
positive cells were calculated using the total number of cells in each image (DAPI
nuclear stain). Data were analysed with Prism 5 software (GraphPad Software)
using a two-way ANOVA test as all data met the common assumptions (normally
distributed, equal variances, independent samples) required for this test.
Neurosphere western blotting. Western blots were performed as previously
described62. Images of full western blots can be seen in Supplementary Figs 8 and
12. In brief, neurospheres were lysed in MAPK lysis buffer (20mM Tris [pH 7.0],
10mM EGTA, 400mM B-glycerophosphate, 1% NP-40, 2.5mM MgCl2 and 2mM
sodium orthovanadate with protease inhibitors (leupeptin, aprotinin and
phenylmethylsulfonyl ﬂuoride). Proteins were separated by SDS–polyacrylamide
gel electrophoresis (SDS–PAGE) and transferred to polyvinylidene diﬂuoride
membranes (Millipore) before detection with phospho-speciﬁc antibodies.
Antibodies that detect the total expression of the corresponding signalling
intermediate (Gpr56-H11 (1:1,000)63; RhoA (1:1,000): #2117, Cell Signaling) as
well as a-tubulin ((1:30,000), T745, Sigma) were used as controls for equal protein
loading and quantitation. Active RhoA (RhoA-GTP) was determined by PAK1-
PBD afﬁnity chromatography ((1:200), M17-294, Millipore) according to the
manufacturer’s recommendations. Appropriate HRP-conjugated secondary
antibodies (anti-rabbit (1:5,000): 7074 and anti-mouse (1:5,000): 7076, Cell
Signaling) were used for detection by enhanced chemiluminescence (New England
Biolabs).
Time-lapse imaging. Embryos were mounted in 1% low melting agarose with
tricaine to prevent movement and 0.003% phenylthiourea to prevent pigmentation.
Embryos were oriented laterally and all images were taken of spinal cord regions
spanning segments 5–7 using a  40 dry objective. Time-lapse images were taken
from gpr56stl13/stl13 mutants (N¼ 7) and gpr56stl13/þ controls (N¼ 6) expressing
tg(sox10:mRFP)24 from 30 to 46 hpf using a Quorum spinning disc confocal
microscope on a heated stage, recorded using Metamorph software, and analysed
using Image J. All analyses were performed blinded to genotype.
Zebraﬁsh immunohistochemistry and ﬂuorescence imaging. For imaging of
transgenes in ﬁxed embryos, embryos were ﬁxed in fresh, 4% paraformaldehyde
supplemented with 0.1M pipes, 1.0mM MgSO4, and 2mM EGTA in 1 PBS to
preserve ﬂuorescence64. For phospho-H3 antibody stains (06570MI, Millipore),
embryos were ﬁxed in 4% paraformaldehyde in 1 PBS overnight (4 C), washed
in 0.3% PBS/Triton and then blocked for 2 h in 0.3% PBS/Triton plus 10% normal
goat serum and 4% BSA. Embryos were then incubated overnight at 4 C in
primary diluted 1:3,000 in blocking solution. For secondary staining, embryos were
incubated in Alexa Flour goat anti-rabbit 488 IgG (Life Technologies) diluted
1:2,000 in 0.3% PBS/Triton plus 2% normal goat serum for 3 h at room
temperature. Finally, embryos were washed and mounted in vectashield (Vector
Labs) for imaging. All quantiﬁcations were performed blinded, and genotypes were
obtained following quantiﬁcation.
Morpholino and synthetic mRNA injections. The morpholinos targeting gna12,
gna13a and gna13b are previously published38 and were a kind gift from Fang Lin
(University of Iowa). Morpholinos were combined and diluted in sterile water
supplemented 1:10 with phenol-red dye, and then injected at a ﬁnal concentration
of 1 ng each in a total volume of 1 nl. To control for adverse side-effects from the
injection process, we also injected control siblings with an equal volume of phenol-
red diluted 1:10 in water. Contstitutively active Rho (rhoV14) was kindly provided
by Lila Solnica-Krezel and was transcribed and injected as described previously38.
The full-length mouse Gpr56 cDNA clone was obtained from Open Biosystems
(Clone ID: 3709247), linearized with NotI, transcribed using the mMESSAGE
mMACHINE SP6 ULTRA kit (Ambion) and injected at a ﬁnal concentration of
200 pg in 2 nl. For transcription of pCS2þ _ zf_gpr56, the plasmid was linearized
with NotI and also transcribed using the mMESSAGE mMACHINE SP6 ULTRA
kit (Ambion) before injection of a total concentration of 50 pg in 3 nl.
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Statistical analyses. All data are presented as the meanþ or±s.d. To represent
signiﬁcance: *, Po0.05; **, Po0.01; ***, Po0.001, a minimum of two technical
replicates were performed for each described experiment unless noted otherwise.
Although we did not perform statistical tests to predetermine sample size, our
sample sizes are similar to previously published studies. For cell-count, molecular
marker and time-lapse imaging analyses in zebraﬁsh, a minimum of six animals per
genotype were used for each described marker, which is in line with previously
published works10,55,57. Similarly, for TEM analyses, a minimum of two WT and
four mutant animals were analysed at each developmental stage as previously
described10,34. For neurosphere studies, we used at least three animals per
genotype, and for IHC experiments cell counts were taken from three nonadjacent
sections of each well in triplicate62. Finally, for injection studies, a minimum of 10
animals were analysed per genotype and treatment group, similar to previously
published studies10,55. Unless otherwise noted, statistical analyses were performed
using an unpaired Student’s t-test with two tails, unequal variance. With few
exceptions, all data sets analysed by a Student’s t-test met the appropriate
assumptions, including normality. All data sets with a skewness and kurtosis with
an absolute value ofr1 were considered approximately normal. The data sets that
did not follow a normal distribution were represented by the following graphs:
Figs 3o, 7j, and Supplementary Fig. 3i. These data sets showed low variability,
causing a kurtosis value of 41. Because the mean and s.d. values were nearly
identical between both control and experimental groups for these experiments, and
we found no signiﬁcant difference between these groups using the student’s t-test,
we did not feel that the test was inappropriate for these analyses.
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